Result: Case Report: Dupilumab therapy for immune checkpoint inhibitor-induced bullous pemphigoid enables dual immunotherapy initiation in progressive malignant melanoma

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2025

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

Frontiers in oncology. - 15 (2025) , 1613552, ISSN: 2234-943X

*DOI*:

10.3389/fonc.2025.1613552

*Result*: Case Report: Dupilumab therapy for immune checkpoint inhibitor-induced bullous pemphigoid enables dual immunotherapy initiation in progressive malignant melanoma